Table 1.
Problem | Recommendations |
Volume status and end points of resuscitation | MAP, TTE, and PAC measurements more reliable than pulse pressure variation or arterial pulse contour |
SvO2 and serum lactate can be inaccurate | |
Fluid resuscitation and vasopressors | Balanced salt solutions recommended over normal saline |
Norepinephrine=pressor of choice | |
Albumin useful in SBP, HRS, and PPCD | |
Ascites management | Preoperative |
Grade 2 ascites: Na+ restriction and diuretics | |
Grade 3: large volume paracentesis | |
Consider preoperative TIPS | |
Postoperative | |
Consider postoperative TIPS | |
No recommendation for fluids or drains | |
Hepatorenal syndrome | Volume expansion with albumin, treatment of infections, stopping diuretics |
MAP >65 mm Hg with norepinephrine versus terlipressin | |
GI bleeding | Ceftriaxone plus vasoactive agent (vasopressin, somatostatin, or octreotide) |
Endoscopy within 12 hours | |
TIPS for recurrent or persistent variceal bleed | |
Coagulopathy | VTE prophylaxis should follow standard of care; can follow viscoelastic testing |
Empiric platelet transfusions not indicated for peri-procedural correction of thrombocytopenia | |
Hepatic encephalopathy | Ammonia can exclude but should not be followed as end point |
Treatment with non-absorbable disaccharides and rifaximin | |
Nutrition | Early enteral nutrition preferred; protein restriction not beneficial |
Hypoglycemia should be aggressively managed | |
Prognosis | Clinical scores include MELD, ACLF criteria, CLIF-SOFA |
Biomarkers being investigated include cystatin C, copeptin, procalcitonin, and CRP |
ACLF, Acute-on-Chronic Liver Failure; CLIF-SOFA, Chronic Liver Failure-Sequential Organ Failure Assessment; CRP, C reactive protein; GI, gastrointestinal; HRS, hepatorenal syndrome; MAP, mean arterial pressure; MELD, Model of End-Stage Liver Disease; Na+, sodium; PAC, pulmonary artery catheter; PPCD, postparacentesis circulatory dysfunction; SBP, spontaneous bacterial peritonitis; SvO2, central venous oxygenation level; TIPS, transjugular intrahepatic portosystemic shunt; TTE, transthoracic echocardiography; VTE, venous thromboembolism.